TABLE 8.
Clinical trials and clinical applications of experimental approaches to increase ABCG1 expression.
| Experimental approach | Clinical trials and applications |
| ABCG1 overexpression | No human applications found |
| Extra virgin olive oila | See Oleocanthal/extra virgin olive oil, Table 4 |
| LXR agonists | See Table 4 |
| PPAR-δ activation | See Table 4 |
| RXR activation (Bexarotene) | See Table 4 |
aConsumption of extra virgin olive oil for 12 weeks by healthy volunteers increased macrophage expression of ABCG1 (Helal et al., 2013).
The approaches, with the exception of ABCG1 overexpression, are the same as listed for ABCA1 in Table 4. ABCG1 ATP binding cassette subfamily G member 1; LXR, liver X receptor; PPAR-δ, Peroxisome proliferator-activated receptor-delta; RXR, retinoid X receptor.